Iron Financial, LLC Bristol Myers Squibb CO Transaction History

Iron Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$40.25 - $52.99 $13,685 - $18,016	340 Added 2.51%	13,870 $576,000
Q1 2024 Apr 23, 2024	BUY	$47.98 - $54.4 $146,818 - $166,464	3,060 Added 29.23%	13,530 $733,000
Q4 2023 Jan 19, 2024	SELL	$48.48 - $57.85 $24,676 - $29,445	-509 Reduced 4.64%	10,470 $537,000
Q3 2023 Oct 31, 2023	BUY	$57.89 - $64.73 $53,606 - $59,939	926 Added 9.21%	10,979 $637,000
Q2 2023 Jul 24, 2023	SELL	$63.71 - $70.74 $4,459 - $4,951	-70 Reduced 0.69%	10,053 $642,000
Q1 2023 Apr 25, 2023	BUY	$65.71 - $74.53 $665,182 - $754,467	10,123 New	10,123 $701,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Iron Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Iron Financial, LLC with notifications on news.